Efficacy and safety of sodium cromolyn eye drops compared with placebo eye drops in patients with a history of allergic conjunctivitis using the Conjunctival Allergen Challenge model.

Registry ID
EUCTR2007-004473-26
Source registry
EUCTR
Status
Ongoing
Phase
PHASE2
Sponsor
Laboratoires Théa
Start date
2007-10-16
Last update
2026-08-16

Conditions

Summary

Evaluation of the efficacy of sodium cromolyn preservative-free ophthalmic solution compared with placebo in the prevention of symptoms of allergic conjunctivitis induced by Conjunctival Allergen Challenge (CAC) (see Appendix II) in patients with a known history of allergic conjunctivitis. This will be assessed through the primary endpoint, which is the itching subject’s assessment by a 5-point scale, 5 minutes after the CAC.

Locations

View on source registry